- Home
- Cardiovascular News
Cardiovascular News
Please find all MAQUET related press releases below. For additional information, please contact us.
FDA 510(k) clearance and CE mark approval for AIR-BAND™...
-
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and European CE mark approval for its new AIR-BAND™ Radial Compression Device.
MAQUET joins Stent For Life initiative
-
MAQUET today announced that it has joined the “Stent for Life” initiative as an industry partner to support a coalition of leading organizations, including the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Society of Cardiology’s Working Group on Acute Cardiac Care, and EuroPCR.
FDA 510(K) Clearance and CE Mark For SENSATION PLUS® 7.5Fr 40cc...
-
October 17, 2012 - MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE mark approval for its new SENSATION PLUS® 7.5Fr. 40cc intra-aortic balloon (IAB) catheter.
MAQUET Announces Acquisition of the Avalon Elite® Bi-Caval...
-
MAQUET Cardiopulmonary, a business unit of MAQUET Cardiovascular and a leader in extracorporeal life support (ECLS) systems, today announced that they have signed an agreement with Avalon Laboratories to acquire its Avalon Elite® Bi- Caval Dual Lumen Catheter and complimentary vascular access kits for use during ECLS.
FDA 510(k) clearance for new MEGA® IAB catheter sizes
-
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new MEGA 7.5Fr. 30cc and 40cc intra-aortic balloon (IAB) catheters.
MAQUET receives CE mark for new MEGA® IAB catheter sizes
-
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, announced today that it has received CE mark for its new MEGA 7.5Fr. 30cc and 40cc intra-aortic balloon catheters.
Elective IABP Associated With 34% Mortality Reduction
-
MAQUET CARDIOVASCULAR ANNOUNCES THAT ELECTIVE USE OF AN INTRA-AORTIC BALLOON PUMP DURING HIGH-RISK PCI IS ASSOCIATED WITH A 34 PERCENT REDUCTION IN ALL-CAUSE MORTALITY. Positive long-term mortality data from BCIS-1 clinical trial to be presented during American College of Cardiology’s 61st Annual Scientific Session.
FDA 510(K) CLEARANCE AND CE MARK FOR THE CARDIOSAVE™...
-
Mahwah, N.J. – November 9, 2011 – MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, announced U.S. Food & Drug Administration (FDA) 510(k) clearance and CE mark today at the 2011 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco for its new CARDIOSAVE intra-aortic balloon pump (IABP). CARDIOSAVE is expected to be commercially available in the United States in January 2012.
Getinge acquires US company Atrium Medical Inc.
-
October 3, 2011 - Getinge to expand within cardiovascular area through acquisition of US company Atrium Medical Inc.
MAQUET Receives EACTS Techno College Innovation Award
-
Wayne, N.J. - October 3, 2011 - MAQUET, a global leader in medical systems, today announced that the company has received the 2011 European Association of Cardio-Thoracic Surgery (EACTS) Techno College Innovation Award for its revolutionary CARDIOHELP System. Approved for use in the United States and Europe, CARDIOHELP is the world's smallest portable heart-lung support system providing extracorporeal life support to replace or support a patient's circulation and respiration. It is the first portable, lightweight device of its kind, and the first support system that can be used for both land and air transportation.
FDA 510(K) Clearance & CE Mark For SENSATION PLUS™ IAB...
-
Mahwah, N.J. - September 20, 2011 - MAQUET Cardiovascular, a leading provider of cardiovascular technologies, announced today that it has received both 510(k) clearance from the U.S. Food & Drug Administration (FDA) and CE mark approval from the British Standards Institution (BSi) for its new SENSATION PLUSTM 50cc 8 Fr. intra-aortic balloon catheter. The new SENATION PLUS intra- aortic balloon (IAB) catheter is the first 50cc 8 Fr. IAB catheter to combine fiber optic signal acquisition with greater hemodynamic support compared to a standard 40cc IAB catheter.
Trial Comparing Use Of MAQUET Pressure Controlling Syringe to...
-
Wayne, N.J. - June 10, 2011 - MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced the initiation of a new prospective trial that is designed to compare the endothelial function of saphenous vein grafts using the MAQUET VASOSHIELD Pressure Controlling Syringe with graft preparation methods using a standard syringe in patients undergoing coronary artery bypass graft (CABG) surgery.
510(K) Clearance To Market CARDIOROOT Aortic Graft In U.S.
-
Wayne, N.J. - May 19, 2011 - MAQUET Cardiovascular today announced that the U.S. Food and Drug Administration has granted the company 510(k) clearance to market its CARDIOROOT aortic graft in the U.S. An innovative, one-piece design, aortic root graft, CARDIOROOT will be used by vascular and cardiovascular surgeons to surgically repair or replace diseased and damaged aortae. CARDIOROOT is now commercially available in the U.S.
MAQUET Announces U.S. Launch of VASOVIEW 6 PRO Endoscopic Vessel...
-
Wayne, N.J. - February 9, 2011 - MAQUET Cardiovascular today announced the U.S. launch of the VASOVIEW 6 PRO Endoscopic Vessel Harvesting System. This latest advance in the VASOVIEW 6 platform for endoscopic vessel harvesting (EVH) offers streamlined controls, improved functionality and simplified operation to support positive outcomes in delivering EVH to patients undergoing cardiac surgery.
MAQUET Announces U.S. Launch of New ACROBAT-i Off-Pump System...
-
Wayne, NJ - January 31, 2011 - MAQUET Cardiovascular today launched its new ACROBAT-i Stabilizer and Positioner System at the Society of Thoracic Surgery Meeting in San Diego. Developed for use in performing off- pump coronary artery bypass (OPCAB) procedures on coronary artery bypass graft (CABG) patients, this next-generation ACROBAT-i System, the latest in the ACROBAT family, has a significantly lower profile design and tubing management features that allow increased access to and visibility of the surgical field.